Milligan GN - Search Results

1

Status of vaccine research and development of vaccines for Nipah virus.

Satterfield BA, Dawes BE, Milligan GN. Satterfield BA, et al. Among authors: milligan gn. Vaccine. 2016 Jun 3;34(26):2971-2975. doi: 10.1016/j.vaccine.2015.12.075. Epub 2016 Mar 11. Vaccine. 2016. PMID: 26973068 Free article.

2

Estradiol improves genital herpes vaccine efficacy in mice.

Pennock JW, Stegall R, Bell B, Vargas G, Motamedi M, Milligan G, Bourne N. Pennock JW, et al. Vaccine. 2009 Sep 25;27(42):5830-6. doi: 10.1016/j.vaccine.2009.07.052. Epub 2009 Aug 4. Vaccine. 2009. PMID: 19660586 Free PMC article.

3

Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine.

Nelson MH, Winkelmann E, Ma Y, Xia J, Mason PW, Bourne N, Milligan GN. Nelson MH, et al. Among authors: milligan gn. Vaccine. 2010 Dec 16;29(2):174-82. doi: 10.1016/j.vaccine.2010.10.069. Epub 2010 Nov 4. Vaccine. 2010. PMID: 21055493 Free PMC article.

4

Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.

Winkelmann ER, Widman DG, Xia J, Ishikawa T, Miller-Kittrell M, Nelson MH, Bourne N, Scholle F, Mason PW, Milligan GN. Winkelmann ER, et al. Among authors: milligan gn. Vaccine. 2012 Feb 14;30(8):1465-75. doi: 10.1016/j.vaccine.2011.12.103. Epub 2012 Jan 5. Vaccine. 2012. PMID: 22226862 Free PMC article.

5

Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.

Fuchs J, Chu H, O'Day P, Pyles R, Bourne N, Das SC, Milligan GN, Barrett AD, Partidos CD, Osorio JE. Fuchs J, et al. Among authors: milligan gn. Vaccine. 2014 Nov 12;32(48):6537-43. doi: 10.1016/j.vaccine.2014.08.087. Epub 2014 Sep 17. Vaccine. 2014. PMID: 25239488 Free PMC article.

6

Mouse models of dengue virus infection for vaccine testing.

Sarathy VV, Milligan GN, Bourne N, Barrett AD. Sarathy VV, et al. Among authors: milligan gn. Vaccine. 2015 Dec 10;33(50):7051-60. doi: 10.1016/j.vaccine.2015.09.112. Epub 2015 Oct 23. Vaccine. 2015. PMID: 26478201 Free PMC article. Review.

7

A combined carrier-adjuvant system of peptide nanofibers and toll-like receptor agonists potentiates robust CD8+ T cell responses.

Rudra JS, Banasik BN, Milligan GN. Rudra JS, et al. Among authors: milligan gn. Vaccine. 2018 Jan 25;36(4):438-441. doi: 10.1016/j.vaccine.2017.12.017. Epub 2017 Dec 14. Vaccine. 2018. PMID: 29248267 Free PMC article.

8

Research and development of Zika virus vaccines.

Dawes BE, Smalley CA, Tiner BL, Beasley DW, Milligan GN, Reece LM, Hombach J, Barrett AD. Dawes BE, et al. Among authors: milligan gn. NPJ Vaccines. 2016 Jul 28;1:16007. doi: 10.1038/npjvaccines.2016.7. eCollection 2016. NPJ Vaccines. 2016. PMID: 29263851 Free PMC article.

9

Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development.

Reece LM, Beasley DW, Milligan GN, Sarathy VV, Barrett AD. Reece LM, et al. Among authors: milligan gn. Curr Opin Virol. 2018 Apr;29:72-78. doi: 10.1016/j.coviro.2018.03.005. Epub 2018 Apr 9. Curr Opin Virol. 2018. PMID: 29642053 Review.

10

Defining a correlate of protection for chikungunya virus vaccines.

Milligan GN, Schnierle BS, McAuley AJ, Beasley DWC. Milligan GN, et al. Vaccine. 2019 Nov 28;37(50):7427-7436. doi: 10.1016/j.vaccine.2018.10.033. Epub 2018 Nov 15. Vaccine. 2019. PMID: 30448337 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters